Clinical Trials Sponsored by Sequential Medicine Ltd

Total 1051 results

Sequential Medicine Ltd

Not yet recruiting

SM-1 vs. an Active Comparator in A Model of Transient Insomnia

Transient Insomnia

United States
Sequential Medicine Ltd

Completed

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

Transient Insomnia

United States
Sequential Medicine Ltd

Withdrawn

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

Transient Insomnia
Sequential Medicine Ltd
Clinilabs, Inc.

Completed

Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia

Short-term Insomnia
LittDD Medicines Ltd

Enrolling by invitation

A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Trio Medicines Ltd.

Completed

Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin

Dyspepsia | ECL-cell Hyperplasia | Parietal-cell Hyperplasia | Rebound Hyperacidity
Trio Medicines Ltd.

Completed

Effects of YF476 and Rabeprazole on Gastric Function

Hypergastrinaemia

United Kingdom
Zhejiang Medicine Co., Ltd.

Unknown

Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

Kidney Dysfunction

China
Stem Cell Medicine Ltd.

Withdrawn

Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

Secondary Progressive Multiple Sclerosis (SPMS)

Israel
Medikine, Inc.
Medikine Australia Pty Ltd.

Completed

A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers

Healthy Volunteers

Australia
M. H MediCane Ltd.

Recruiting

A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.

Dementia | Alzheimer Disease | Agitation,Psychomotor | Disruptive Behavior

Israel
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Advanced KRAS G12D Mutant Solid Tumors

China
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

Advanced Malignant Tumour
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

Obstructive Hypertrophic Cardiomyopathy
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.

Adult Patients With Chronic Primary ITP | Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures

Sedation in Non-intubated Diagnostic and Therapeutic Procedures

China
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects

Inflammatory Bowel Disease
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults

Gout With Hyperuricemia in Adults
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma

Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy

China
Hope Medicine (Nanjing) Co., Ltd

Recruiting

A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia

Androgenetic Alopecia

China
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

Chronic Kidney Disease
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

Advanced Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects

Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study of SHR-A1811 in Subjects With Gynaecologic Oncology

Gynaecological Malignancies

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Advanced Gastroenteropancreatic Neuroendocrine Tumor

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

Castration-Resistant Prostate Cancer

China
Chengdu Suncadia Medicine Co., Ltd.

Recruiting

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Glomerulonephritis

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

Autoimmune Hepatitis

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer

Advanced Esophageal Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane

HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults

Primary Gout With Hyperuricemia in Adults
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis

Non-radiographic Axial Spondyloarthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors

Advanced Malignant Tumor
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial of HR17031 Injection With Renal Insufficiency

Improved Glycemic Control in Patients With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject

Diabetes in Adults
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Extension Study of Hetrombopag in Severe Aplastic Anemia

Treatment-naive Severe Aplastic Anemia

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects

Pain
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Immune Thrombocytopenia

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants

Hepatic Impairment | Healthy Participants

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients

Relapsed Ovarian Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer

Pancreatic Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Renal Cell Carcinoma | Cervical Cancer | Endometrial Cancer | Urothelial Carcinoma | Ovarian Cancer Recurrent

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

SHR-1701 in Metastatic or Locally Advanced Solid Tumors

Solid Tumor

China

Clinical Trials Sponsored by Sequential Medicine Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations